| Title |
Non‐immunosuppressive treatment for IgA nephropathy
|
|---|---|
| Published in |
Cochrane database of systematic reviews, March 2011
|
| DOI | 10.1002/14651858.cd003962.pub2 |
| Pubmed ID | |
| Authors |
Sharon Reid, Peggy M Cawthon, Jonathan C Craig, Joshua A Samuels, Donald A Molony, Giovanni FM Strippoli |
| Abstract |
IgA nephropathy (IgAN) is the most common primary glomerular disease with approximately 30% to 40% of patients progressing to end-stage kidney disease (ESKD) within 20 years. The most common regimens include immunosuppressive agents, however the risks of long-term treatment often outweigh the potential benefits. Non-immunosuppressive options, including fish oils, anticoagulants, antihypertensive agents and tonsillectomy have also been examined but not reviewed systematically. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Central African Republic | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 184 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Germany | 2 | 1% |
| United States | 2 | 1% |
| United Kingdom | 1 | <1% |
| Unknown | 179 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 28 | 15% |
| Researcher | 24 | 13% |
| Student > Ph. D. Student | 17 | 9% |
| Student > Bachelor | 17 | 9% |
| Student > Postgraduate | 15 | 8% |
| Other | 34 | 18% |
| Unknown | 49 | 27% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 86 | 47% |
| Nursing and Health Professions | 13 | 7% |
| Agricultural and Biological Sciences | 5 | 3% |
| Psychology | 4 | 2% |
| Biochemistry, Genetics and Molecular Biology | 3 | 2% |
| Other | 14 | 8% |
| Unknown | 59 | 32% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 February 2016.
All research outputs
#16,292,673
of 25,728,855 outputs
Outputs from Cochrane database of systematic reviews
#11,226
of 13,136 outputs
Outputs of similar age
#92,914
of 120,197 outputs
Outputs of similar age from Cochrane database of systematic reviews
#85
of 99 outputs
Altmetric has tracked 25,728,855 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 13,136 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.8. This one is in the 13th percentile – i.e., 13% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 120,197 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 21st percentile – i.e., 21% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 99 others from the same source and published within six weeks on either side of this one. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.